The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.
Christina Caroline PlaschkeHelle Hjorth JohannesenRasmus Hvass HansenHelle Westergren HendelKatalin KissJulie GehlIrene WesselPublished in: Head & neck (2018)
Electrochemotherapy is efficient against local recurrence of head and neck cancer with an overall response rate of 58%.
Keyphrases